Skip to content

Rakesh Jhunjhunwala-backed Concord Biotech files draft papers to float IPO

The active pharmaceutical ingredients (API) maker is also backed by ace investor Rakesh Jhunjhunwalal who died on Sunday. Jhunjhunwala holds over 24% stake in the firm through its investment arm Rare Enterprises

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish